Literature DB >> 6268817

Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions.

W W Newcomb, J C Brown.   

Abstract

Vesicular stomatitis virus was extracted with 60 mM octylglucoside in the absence of salts and in the presence of 0.5 M NaCl. The resulting extracted virus particles were examined by electron microscopy, and the proteins present were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Extraction in the absence of salts yielded subviral structures which we cell "skeletons" as originally suggested by Cartwright et al. (J. Gen. Virol. 7:19-32, 1970). The skeletons contained the viral N, M, and L proteins, but they lacked the glycoprotein (G) entirely. Morphologically, the skeletons resembled intact vesicular stomatitis virus but they were slightly longer and smaller in diameter. Like native vesicular stomatitis virus, skeletons were found to have lateral striations spaced 5.0 to 6.0 nm apart along the length of the structure. In contrast to extraction in the absence of NaCl, extraction of vesicular stomatitis virus with 60 mM octylglucoside in the presence of 0.5 M NaCl yielded highly extended viral nucleocapsids in which N was the predominant protein; no M or G proteins could be detected. These results support the view that the M protein is involved in maintaining the nucleocapsid in the compact form found in native virions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268817      PMCID: PMC171289     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Glycoprotein fragment associated with vesicular stomatitis virus after proteolytic digestion.

Authors:  J A Mudd
Journal:  Virology       Date:  1974-12       Impact factor: 3.616

3.  The proteins of biologically active sub-units of vesicular stomatitis virus.

Authors:  B Cartwright; P Talbot; F Brown
Journal:  J Gen Virol       Date:  1970-06       Impact factor: 3.891

4.  Infective virus substructure from vesicular stomatitis virus.

Authors:  F Brown; B Cartwright; J Crick; C J Smale
Journal:  J Virol       Date:  1967-04       Impact factor: 5.103

5.  Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components.

Authors:  B Cartwright; C J Smale; F Brown
Journal:  J Gen Virol       Date:  1970-04       Impact factor: 3.891

6.  The fine structure of vesicular stomatitis virus.

Authors:  T Nakai; A F Howatson
Journal:  Virology       Date:  1968-06       Impact factor: 3.616

Review 7.  The budding mechanisms of enveloped animal viruses.

Authors:  K Simons; H Garoff
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

8.  Conformation of the helical nucleocapsids of paramyxoviruses and vesicular stomatitis virus: reversible coiling and uncoiling induced by changes in salt concentration.

Authors:  M H Heggeness; A Scheid; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

9.  Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents.

Authors:  J J Zakowski; R R Wagner
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Protein composition of the structural components of vesicular stomatitis virus.

Authors:  R R Wagner; T C Schnaitman; R M Snyder; C A Schnaitman
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103

View more
  45 in total

1.  Structure of the RNA inside the vesicular stomatitis virus nucleocapsid.

Authors:  F Iseni; F Baudin; D Blondel; R W Ruigrok
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

2.  VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment.

Authors:  Larissa Kolesnikova; Harald Bugany; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release.

Authors:  H R Jayakar; K G Murti; M A Whitt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Genetic inactivation of COPI coatomer separately inhibits vesicular stomatitis virus entry and gene expression.

Authors:  David K Cureton; Rebeca Burdeinick-Kerr; Sean P J Whelan
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

5.  Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction.

Authors:  John H Connor; Margie O McKenzie; Douglas S Lyles
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids.

Authors:  P E Kaptur; R B Rhodes; D S Lyles
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Subunit interactions of vesicular stomatitis virus envelope glycoprotein stabilized by binding to viral matrix protein.

Authors:  D S Lyles; M McKenzie; J W Parce
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties.

Authors:  Piotr Neumann; Diana Lieber; Sylke Meyer; Philipp Dautel; Andreas Kerth; Ina Kraus; Wolfgang Garten; Milton T Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

9.  Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein.

Authors:  Chad E Mire; Derek Dube; Sue E Delos; Judith M White; Michael A Whitt
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  Rabies virus M protein expressed in Escherichia coli and its regulatory role in virion-associated transcriptase activity.

Authors:  Y Ito; A Nishizono; K Mannen; K Hiramatsu; K Mifune
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.